The product portfolio of Richter covers many important therapeutic areas, including Women’s Healthcare, Central Nervous System and Cardiovascular areas. Having the largest R&D unit in Central Eastern Europe, Richter’s original research activity focuses on CNS disorders. With its widely acknowledged steroid chemistry expertise, Richter is a significant player in the Women’s Healthcare field worldwide. Richter is also active in biosimilar product development.
Since 1996, the medicines of the Gedeon Richter company have been present on the Kazakhstani pharmaceutical market. Over more than 25 years company has proven its partnership with government agencies and the medical community. Today, the company is present in all regions of our country and is one of the largest pharmaceutical companies operating in the Republic of Kazakhstan.